Prolonged stability of stored vancomycin, gentamicin, and heparin for use in the antibiotic-lock technique

被引:8
作者
Bastani, B [1 ]
Amin, K [1 ]
Herr, A [1 ]
机构
[1] St Louis Univ, Sch Med, Dept Internal Med, Div Nephrol, St Louis, MO 63110 USA
关键词
D O I
10.1097/01.mat.0000183656.75618.09
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The antibiotic-lock technique has been effective in salvaging tunneled catheters in hemodialysis patients with bacteremia. However, a practical concern exists with respect to the stability of the antibiotics and heparin in normal saline, when stored for a prolonged period. Vancomycin, gentamicin, and heparin were diluted in normal saline to a final concentration of 100 mu g/ml of each antibiotic and 5000 units/ml heparin. Fresh samples, and samples refrigerated at VC for 48 hours, 1 week, 2 weeks, 3 weeks, and 4 weeks, were assayed (in triplicate) for gentamicin and vancomycin concentration and bactericidal activity (Schlichter test) using methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. An anti-Xa activity assay was used for monitoring heparin anticoagulant activity of the fresh samples and samples refrigerated for 2 and 4 weeks. Mean (SD) anti-Xa activity for heparin/vancomycin solution was 7900 +/- 173 u/ml, and for heparin/gentamicin solution was 7467 +/- 751 u/ml; both were stable over a 4-week storage period. Mean bactericidal titer for vancomycin was 1:121 +/- 11, and for gentamicin was 1:242 +/- 22; both were stable over a 4-week storage period. Mean vancomycin concentration was 97 +/- 4 mu g/ml, and gentamicin concentration was 86 +/- 3 mu g/ml; both were stable over a 4-week storage period. Vancomycin and gentamicin in a heparin/saline solution can be stored at VC for up to 4 weeks without adversely affecting antibiotic concentration, bactericidal activity, or heparin anticoagulant activity.
引用
收藏
页码:761 / 763
页数:3
相关论文
共 21 条
[11]  
Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001
[12]   USE OF A SILICONE DUAL-LUMEN CATHETER WITH A DACRON CUFF AS A LONG-TERM VASCULAR ACCESS FOR HEMODIALYSIS-PATIENTS [J].
MOSS, AH ;
VASILAKIS, C ;
HOLLEY, JL ;
FOULKS, CJ ;
PILLAI, K ;
MCDOWELL, DE .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 16 (03) :211-215
[13]  
*NKF DOQI CLIN PRA, 2001, AM J KIDNEY DIS S, V37, pS166
[14]   BIOFILMS ON INDWELLING VASCULAR CATHETERS [J].
PASSERINI, L ;
LAM, K ;
COSTERTON, JW ;
KING, EG .
CRITICAL CARE MEDICINE, 1992, 20 (05) :665-673
[15]   INHIBITORY EFFECT OF HEPARIN ON GENTAMICIN CONCENTRATIONS IN BLOOD [J].
REGAMEY, C ;
SCHABERG, D ;
KIRBY, WMM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1972, 1 (04) :329-&
[16]  
RILEY BB, 1970, J HOSP PHARM, V28, P228
[17]   Bacteremia associated with tunneled, cuffed hemodialysis catheters [J].
Saad, TF .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (06) :1114-1124
[18]   The hemodialysis catheter conundrum: Hate living with them, but can't live without them [J].
Schwab, SJ ;
Beathard, G .
KIDNEY INTERNATIONAL, 1999, 56 (01) :1-17
[19]  
SWARTZ RD, 1994, J AM SOC NEPHROL, V4, P1719
[20]   National surveillance of dialysis-associated diseases in the United States, 1997 [J].
Tokars, JI ;
Miller, ER ;
Alter, MJ ;
Arduino, MJ .
SEMINARS IN DIALYSIS, 2000, 13 (02) :75-85